The shift from traditional small-molecule based drugs to biologic compounds has created significant opportunities for the pharmaceutical industry. However, biopharma companies continue to face key barriers, such as siloed infrastructure, a lack of innovative tools, and slow lead and response times.
Danaher Life Sciences companies apply the Danaher Business System (DBS) as the foundation of our culture.
We do not accept the status quo, we aim for continuous process improvement. Whether applied to developing life-saving therapies, industrializing biology or a wide variety of other meaningful efforts, DBS empowers us to apply our culture of innovation to strive for transformation in the biopharmaceutical industry..
